Market revenue in 2021 | USD 48.6 million |
Market revenue in 2030 | USD 92.4 million |
Growth rate | 7.4% (CAGR from 2021 to 2030) |
Largest segment | Biomarker assay development & validation |
Fastest growing segment | Flow cytometry |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biomarker Assay Development & Validation, Flow cytometry, Others( Biomarker immunoassays, Biomarker Assessment) |
Key market players worldwide | Eurofins Scientific SE, SGS AG, Charles River Laboratories International Inc, Labcorp Drug Development, Thermo Fisher Scientific Inc, Icon PLC, IQVIA Holdings Inc, Syneos Health, Intertek Group PLC, BioAgilytix Labs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarker testing services market will help companies and investors design strategic landscapes.
Biomarker assay development & validation was the largest segment with a revenue share of 59.67% in 2024. Horizon Databook has segmented the Asia Pacific biomarker testing services market based on biomarker assay development & validation, flow cytometry, others( biomarker immunoassays, biomarker assessment) covering the revenue growth of each sub-segment from 2018 to 2030.
The region is an attractive biomarker testing services market. Companies established in Asia Pacific typically prioritize China, Japan, India, and South Korea market due to their market size. In addition, rapid economic growth and increasing healthcare expenditure are anticipated to drive the market.
Additionally, growth can be attributed to changing market dynamics, emphasis on personalized and precision medicines, growing prevalence of chronic diseases, rising healthcare expenditure, an increasing number of outsourcing projects, growing research and development activities, and accelerating clinical trials providing accurate, reliable data with biomarker testing.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biomarker testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biomarker testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account